BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8810307)

  • 1. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor.
    Green SP; Chuntharapai A; Curnutte JT
    J Biol Chem; 1996 Oct; 271(41):25400-5. PubMed ID: 8810307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
    Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
    Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
    Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
    Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.
    Luu NT; Rainger GE; Nash GB
    J Immunol; 2000 Jun; 164(11):5961-9. PubMed ID: 10820279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
    Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH
    J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78.
    Bozic CR; Gerard NP; Gerard C
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):302-8. PubMed ID: 8845182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
    Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
    J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA.
    Walz A; Meloni F; Clark-Lewis I; von Tscharner V; Baggiolini M
    J Leukoc Biol; 1991 Sep; 50(3):279-86. PubMed ID: 1856598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells.
    Mueller SG; Schraw WP; Richmond A
    J Biol Chem; 1994 Jan; 269(3):1973-80. PubMed ID: 8294449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity.
    L'Heureux GP; Bourgoin S; Jean N; McColl SR; Naccache PH
    Blood; 1995 Jan; 85(2):522-31. PubMed ID: 7812007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
    Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
    Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C terminus of the interleukin 8 receptor in signal transduction and internalization.
    Prado GN; Suzuki H; Wilkinson N; Cousins B; Navarro J
    J Biol Chem; 1996 Aug; 271(32):19186-90. PubMed ID: 8702597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2.
    Sanchez X; Suetomi K; Cousins-Hodges B; Horton JK; Navarro J
    J Immunol; 1998 Jan; 160(2):906-10. PubMed ID: 9551928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.